S2Medical AB (publ) (S2M.ST)

SEK 0.01

(4.55%)

Operating Expenses Summary of S2Medical AB (publ)

S2Medical AB (publ)'s latest annual operating expenses in 2023 was 20.3 Million SEK , down -38.21% from previous year.
S2Medical AB (publ)'s latest quarterly operating expenses in 2024 Q2 was -4.17 Million SEK , down -225.9% from previous quarter.
S2Medical AB (publ) reported a annual operating expenses of 32.85 Million SEK in annual operating expenses 2022, up 21.98% from previous year.
S2Medical AB (publ) reported a annual operating expenses of 26.93 Million SEK in annual operating expenses 2021, up 7.8% from previous year.
S2Medical AB (publ) reported a quarterly operating expenses of -4.17 Million SEK for 2024 Q2, down -225.9% from previous quarter.
S2Medical AB (publ) reported a quarterly operating expenses of 5.25 Million SEK for 2023 Q1, down -30.27% from previous quarter.

Annual Operating Expenses Chart of S2Medical AB (publ) (2023 - 2015)

Historical Annual Operating Expenses of S2Medical AB (publ) (2023 - 2015)

Year	Operating Expenses	Operating Expenses Growth
2023	20.3 Million SEK	-38.21%
2022	32.85 Million SEK	21.98%
2021	26.93 Million SEK	7.8%
2020	24.98 Million SEK	12.35%
2019	22.23 Million SEK	44.62%
2018	15.37 Million SEK	115.95%
2017	7.12 Million SEK	96.41%
2016	3.62 Million SEK	368.45%
2015	773.82 Thousand SEK	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	3.31 Million SEK	-11.6%
2024 Q2	-4.17 Million SEK	-225.9%
2023 Q1	5.25 Million SEK	-30.27%
2023 FY	606.11 Thousand SEK	-98.16%
2023 Q3	4.36 Million SEK	-36.92%
2023 Q4	3.74 Million SEK	-14.22%
2023 Q2	6.92 Million SEK	31.75%
2022 Q2	8.65 Million SEK	1.98%
2022 Q1	8.48 Million SEK	6.42%
2022 FY	32.85 Million SEK	21.98%
2022 Q4	7.53 Million SEK	-3.25%
2022 Q3	7.79 Million SEK	-9.94%
2021 FY	26.93 Million SEK	7.8%
2021 Q1	6.47 Million SEK	-3.2%
2021 Q3	5.78 Million SEK	-13.71%
2021 Q4	7.97 Million SEK	37.8%
2021 Q2	6.7 Million SEK	3.55%
2020 FY	24.98 Million SEK	12.35%
2020 Q3	5.53 Million SEK	-21.71%
2020 Q4	6.68 Million SEK	20.87%
2020 Q2	7.06 Million SEK	24.07%
2020 Q1	5.69 Million SEK	-23.43%
2019 Q2	5.99 Million SEK	44.72%
2019 Q1	4.14 Million SEK	-16.66%
2019 FY	22.23 Million SEK	44.62%
2019 Q4	7.43 Million SEK	59.8%
2019 Q3	4.65 Million SEK	-22.33%
2018 Q2	2.47 Million SEK	3.95%
2018 FY	15.37 Million SEK	115.95%
2018 Q4	4.96 Million SEK	-5.69%
2018 Q3	5.26 Million SEK	112.89%
2018 Q1	2.38 Million SEK	6.05%
2017 Q2	1.31 Million SEK	0.0%
2017 Q3	2.24 Million SEK	70.73%
2017 FY	7.12 Million SEK	96.41%
2017 Q1	1.31 Million SEK	0.0%
2017 Q4	2.24 Million SEK	0.0%
2016 FY	3.62 Million SEK	368.45%
2015 FY	773.82 Thousand SEK	0.0%

Peer Operating Expenses Comparison of S2Medical AB (publ)

Name	Operating Expenses	Operating Expenses Difference
AddLife AB (publ)	3.01 Billion SEK	99.326%
Biotage AB (publ)	637 Million SEK	96.813%
Bonesupport Holding AB (publ)	510.93 Million SEK	96.027%
Doxa AB (publ)	-259.5 Million SEK	107.823%
Elekta AB (publ)	3.39 Billion SEK	99.401%
iZafe Group AB (publ)	35.92 Million SEK	43.496%
Ortivus AB (publ)	48.45 Million SEK	58.102%
Ortivus AB (publ)	48.45 Million SEK	58.102%
Q-linea AB (publ)	-43 Thousand SEK	47311.319%
Synsam AB (publ)	3.76 Billion SEK	99.46%